Meg Rivers

Meg Rivers is the former senior editor for Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International.


IND Applications Face Challenges Early On in Development Cycle

Avoiding roadblocks through strategic planning early on can help facilitate IND application filings.

The Next Step For COVID-19 Vaccines

New technologies are treatments are emerging to tackle COVID-19 and its assortment of new variants.